The global coronary artery bypass graft market size is anticipated to reach USD 27.66 billion by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 3.5% from 2026 to 2033. The primary factor driving the industry is an increase in the prevalence of hypertension and cases of myocardial infarction. The American Heart Association estimated that in 2020, Coronary Heart Disease (CHD) was the leading cause of death in the U.S. In addition, the rising technological advancements have led to the development of endoscopic bypass surgery that offers various benefits compared to traditional bypass surgery. Such kind of advancements are contributing to the market growth. Furthermore, the rising geriatric population is influencing market growth.
The aged population is more prone to coronary artery blockages, and studies show that the average age of people undergoing Coronary Artery Bypass Graft (CABG) procedures is approximately older than 66 years. The COVID-19 pandemic had a negative impact on many industries and the CABG market was also highly affected. A study published by the University of Alabama at Birmingham shows an approximately 36% decline in patients undergoing bypass surgery. Many routine procedures were limited due to a workforce shortage. In addition, the supply of raw materials for the devices was limited in the initial phase of COVID-19. Thus, the above-mentioned factors lowered the manufacturing and production of devices.
Request a free sample copy or view report summary: Coronary Artery Bypass Graft Market Report
By method, the on-pump segment dominated the market in 2025 and accounted for the largest revenue share of 66.66%. The off-pump segment is anticipated to witness the fastest CAGR over the forecast period.
By surgical procedure, the triple CABG surgery segment dominated the coronary artery bypass graft market in 2025 and accounted for the largest revenue share of 41.74%. The single CABG surgery segment is anticipated to witness the fastest CAGR over the forecast period.
By end-use, the hospitals segment dominated the market in 2025 with a revenue share of 52.25%. The cardiology centers segment of the coronary artery bypass graft market is anticipated to register the fastest growth rate over the forecast period.
North America coronary artery bypass graft market dominated in 2025 and accounted for the largest revenue share of 51.10% owing to a well-established healthcare infrastructure and high healthcare expenditure.
The coronary artery bypass graft market in the U.S. held the largest share in 2025. The Canada market is anticipated to register the fastest growth rate during the forecast period.
Grand View Research, Inc. has segmented the global coronary artery bypass graft market report based on method, surgical procedure, end use, and region:
Coronary Artery Bypass Graft Method Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
On-pump
Minimally Invasive Direct CABG (MIDCAB)
Coronary Artery Bypass Graft Surgical Procedure Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
Single CABG Surgery
Double CABG Surgery
Triple CABG Surgery
Quadruple CABG Surgery
Coronary Artery Bypass Graft End Use Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
Cardiology Centers
Others
Coronary Artery Bypass Graft Regional Outlook Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
U.S.
Canada
Mexico
Europe
Germany
U.K.
Spain
Italy
France
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players in the Coronary Artery Bypass Graft Market
Medtronic
Terumo Corporation
Getinge AB
W. L. Gore & Associates, Inc.
B. Braun SE
Abbott.
LivaNova plc
Transonic.
Edwards Lifesciences
Vascular Graft Solutions
"The quality of research they have done for us has been excellent..."